Contradictory results have also been published for dopamine receptor D1 (DRD1), as both inhibition as well as stimulation of tumour growth has been reported upon receptor activation in animal models of ovarian cancer and breast cancer [6, 8, 9]. This evidence concerns the gene DRD1 and neoplasm.